Literature DB >> 15838246

Genetic studies of chondrocalcinosis.

Yun Zhang1, Matthew A Brown.   

Abstract

PURPOSE OF REVIEW: Our understanding of the causation of the chondrocalcinosis and other disorders characterized by ectopic mineralization is rapidly increasing, and genetic studies have contributed substantially to recent major advances in the field. This review will discuss what is known about the genetics of chondrocalcinosis and what we have learned from genetic studies to date. RECENT
FINDINGS: Chondrocalcinosis is one of a family of conditions associated with ectopic mineralization. This family also includes disorders of mineralization of bone and spinal and other ligaments, and vascular calcification. There has been increasing evidence of the key role of transport and metabolism of inorganic pyrophosphate (PPi) in control of mineralization, and as the likely explanation for the association of a variety of genetic variants with chondrocalcinosis and ectopic mineralization elsewhere. This may be an overly simplistic view of this family of conditions, with recent evidence suggesting that, for example, ANKH variants may not all predispose to chondrocalcinosis by effects on PPi transport, but may also influence chondrocyte maturation.
SUMMARY: Understanding the control of the process of mineralization and its tissue specificity are important steps in the search for rational therapies for these conditions.

Entities:  

Mesh:

Year:  2005        PMID: 15838246     DOI: 10.1097/01.bor.0000157042.19740.f4

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  4 in total

1.  Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.

Authors:  Axel Finckh; Geraldine M Mc Carthy; Anne Madigan; Daniel Van Linthoudt; Marcel Weber; David Neto; Georges Rappoport; Sandra Blumhardt; Diego Kyburz; Pierre-Andre Guerne
Journal:  Arthritis Res Ther       Date:  2014-10-15       Impact factor: 5.156

2.  [Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].

Authors:  N Announ; P-A Guerne
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

3.  Histone Deacetylase Inhibitors Downregulate Calcium Pyrophosphate Crystal Formation in Human Articular Chondrocytes.

Authors:  Chi-Ching Chang; Kun-Lin Lee; Tze-Sian Chan; Chia-Chen Chung; Yu-Chih Liang
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

Review 4.  Extracellular pyrophosphate in the kidney: how does it get there and what does it do?.

Authors:  Shabbir H Moochhala
Journal:  Nephron Physiol       Date:  2012-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.